MCF Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
MCF Advisors's VRTX Position: Q2 2026 in Review
MCF Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 129% in Q2 2026, buying an estimated $113K and bringing the position to 451 shares worth $224K. The position accounts for 0.01% of the portfolio, ranked #411.
MCF Advisors first reported a position in VRTX in Q3 2021 and has held it in 19 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- MCF Advisors held 451 shares of Vertex Pharmaceuticals worth $224K as of Q2 2026.
- MCF Advisors bought 254 Vertex Pharmaceuticals shares in Q2 2026, an estimated $113K.
- Vertex Pharmaceuticals made up 0.01% of MCF Advisors's portfolio in Q2 2026, its #411 holding.
- MCF Advisors first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.